CESSA Share Price Performance
DKK 10.20
-4.50 (-30.61%)
Price DKK 10.20
Share PriceDKK 10.20
Cessatech A/S Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 2 Fair Values set on narratives written by author
CESSA Community Narratives
There are no narratives available yet.
There are no community narratives available.
Snowflake Analysis
Cessatech A/S Key Details
About CESSA
- Founded
- 2020
- Employees
- 4
- CEO
- WebsiteView website
Cessatech A/S, a pharmaceutical company, develops and commercializes medicines for the treatment of pediatric acute pain in Denmark. The company’s lead product is CT001, an analgesic nasal spray for the treatment of acute and planned painful procedures in children. It also develops CT002, a nasal spray for sedative procedures for children from 0-17 years of age; and CT003, a local anesthetic gel. The company has a collaboration and license agreement with Ventis Pharma Corporation to develop and formulate pain management therapies. Cessatech A/S was founded in 2020 and is based in Copenhagen, Denmark.
